BioLumic Overview
- Founded
-
2012
- Status
-
Private
- Employees
-
32
- Latest Deal Type
-
Series B
- Latest Deal Amount
-
$13.7M
- Investors
-
29
BioLumic General Information
Description
Developer of UV crop enhancement systems designed to address growing agricultural concerns. The company's systems utilize UV radiations, which can regulate numerous responses in living organisms and apply them to young plants, priming them to thrive and survive, enabling farmers to increase crop yields, fungal resistance in transplant seedlings and enhance color and taste in indoor grown products.
Contact Information
Website
www.biolumic.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Agriculture
Other Industries
Cultivation
Primary Office
- 21 Dairy Farm Road
- Palmerston North, 4440
- New Zealand
+64 06-352 0000
BioLumic Timeline
BioLumic Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 8. Later Stage VC (Series B) | 07-Mar-2022 | $13.7M | 000.00 | 000.00 | Completed | Generating Revenue |
| 7. Grant | 01-Sep-2020 | 000.00 | 000.00 | Completed | Generating Revenue | |
| 6. Later Stage VC (Series A) | 01-May-2020 | 00.00 | 000.00 | 000.00 | Completed | Generating Revenue |
| 5. Later Stage VC | 01-Dec-2017 | 00.000 | 00.000 | Completed | Generating Revenue | |
| 4. Early Stage VC | 01-Dec-2014 | 00000 | 00.000 | 00.000 | Completed | Startup |
| 3. Grant | 00000 | Completed | Startup | |||
| 2. Seed Round | 16-Oct-2013 | $350K | $350K | 00.000 | Completed | Startup |
| 1. Early Stage VC | 26-Sep-2013 | Completed | Startup |
BioLumic Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series B-3 | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series B-2 | 000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series B-1 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A-3 | 0,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series A-2 | 849,193 | $0.000100 | 8% | $3.16 | $3.16 | 1x | $3.16 | 10.83% |
| Series A-1 | 191,235 | $0.000100 | 8% | $2.52 | $2.52 | 1x | $2.52 | 2.44% |
BioLumic Comparisons
Description
Primary
Industry
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Developer of UV crop enhancement systems designed to address growing agricultural concerns. The company's systems utiliz
Other Agriculture
Palmerston North, New Zealand
32
As of 2022
000.00
00.00
0000-00-00
00000000000
000.00
00000
lore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliqui
00000000000
Emeryville, CA
00
As of 0000
000.00
0000
0000-00-00
00000000000
000.00
000000
agna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut aliquip ex e
00000 00000000000
Boston, MA
00
As of 0000
0000
000000000 -
0000
Add Comparison
BioLumic Competitors (3)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Sound Agriculture | Venture Capital-Backed | Emeryville, CA | 00 | 000.00 | 00000000000 | 000.00 |
| 0000000 00000 | Venture Capital-Backed | Boston, MA | 00 | 0000 | 000000000 - | 0000 |
| 00000000000 | Venture Capital-Backed | North Bend, NE | 0 | 000 | 0000000000 0 | 000 |
BioLumic Patents
BioLumic Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2019376891-A1 | Uv-b induced plant pathogen resistance | Pending | 09-Nov-2018 | 000000000 | |
| CA-3119316-A1 | Uv-b induced plant pathogen resistance | Pending | 09-Nov-2018 | 000000000 | |
| EP-3876697-A2 | Uv-b induced plant pathogen resistance | Pending | 09-Nov-2018 | 000000000 | |
| US-20210298243-A1 | Uv-b induced plant pathogen resistance | Pending | 09-Nov-2018 | 000000000 | |
| US-20200190532-A1 | High growth and high hardiness transgenic plants | Pending | 21-Aug-2017 | C12N15/8273 |
BioLumic Executive Team (7)
| Name | Title | Board Seat | Contact Info |
|---|---|---|---|
| Steven Sibulkin | Chief Executive Officer | ||
| Richard Perry | Chief Financial Officer | ||
| Jason Wargent Ph.D | Founder & Chief Scientific Officer |
BioLumic Board Members (13)
| Name | Representing | Role | Since |
|---|---|---|---|
| Adrian Percy | Finistere Ventures | Chairman | 000 0000 |
| Dean Tilyard | Self | Board Member | 000 0000 |
| Eli Nir | Self | Board Member | 000 0000 |
| Ingrid Fung | Finistere Ventures | Board Observer | 000 0000 |
| John Bedbrook Ph.D | Self | Board Member | 000 0000 |
BioLumic Signals
Growth Rate
0.80%
Weekly
Growth
Growth
Weekly Growth
0.80%, 93rd %
-35.5%.
530%
Size Multiple
219x
Median
Size Multiple
219x, 100th %ile
0.00x
0.95x.
413Kx
Key Data Points
Twitter Followers
5.5k
Similarweb Unique Visitors
15.0K
Majestic Referring Domains
314
BioLumic Investors (29)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| Arcview Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Booster NZ | Asset Manager | Minority | 000 0000 | 000000 0 | |
| Bravos Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Entourage Effect Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Flatiron Venture Partners | Venture Capital | Minority | 000 0000 | 000000 0 |